Search…

New Stock News | "First Stock of Innovative Nephropathy Drug" Knocking on Hong Kong Stock Exchange: Lieubon Medicine Attends Hearing, Core Pipeline Enters Cash-Out Window

14/06/2026

According to the China Times Finance app, it was learned that Lehman Pharmaceutical, a company specializing in kidney disease, held its listing hearing on the main board of the Hong Kong Stock Exchange on June 14th. Jefferies, Bank of America Securities, and Huatai Securities are the joint sponsors, and it is expected to become the first Hong Kong stock of "innovative drugs for kidney disease".

Latest

5 m ago

A Swiss referendum proposal has been rejected, which originally aimed to set a population cap of 10 million by 2050. Preliminary vote count results show that 55% of voters cast their votes against, while 45% expressed support.

17 m ago

Qatar has set the official selling price for July's offshore crude oil at $6.00 per barrel above the average Oman/Dubai price, and the official selling price for onshore crude oil at $6.50 per barrel above the average Oman/Dubai price.

21 m ago

"Zhang Xue Motorcycle" came in ninth place in the second round of Emilia-Romagna station.

27 m ago

The international oil price surged rapidly late at night, while the cryptocurrency took a dive.

28 m ago

Technology journalist Gulman: The new version of Siri, after fifteen years of development, has finally achieved the expected level of usability. With the advantage of being pre-installed on devices, Apple has been able to establish a strong foothold in the competition with ChatGPT, Google Gemini, and Claude, and is expected to attract users of mainstream artificial intelligence basic scenarios.

See all latest